CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.
Acquisition to expand the neuromodulation offerings for people living with chronic pain MARLBOROUGH, Mass., Oct. 17, 2025 ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”), a Carlsbad, California-based neurostimulation company that has miniaturized neurostimulation implants for the management of chronic ...
CareFirst BCBS Recognizes Nalu Neurostimulation System as Medically Necessary for Chronic Peripheral Pain, Expanding Access to 3.5 Million Covered Lives Nalu Medical, Inc., a leader in miniaturized ...
Boston Scientific (NYSE:BSX) will acquire Nalu Medical for $533M in cash for the equity it does not already own. Nalu specializes in peripheral nerve stimulation devices for treating chronic pain in ...
Nalu Medical, Inc., a leader in miniaturized neuromodulation therapies, is pleased to announce that Aetna Inc. has issued an updated medical policy designating the Nalu Neurostimulation System as ...
MARLBOROUGH, Mass., Oct. 17, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback